Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ephrin receptors (Eph receptors) are the largest family of receptor tyrosine kinases (RTKs) in humans, playing crucial roles in cell communication, development, and disease processes such as cancer and immune regulation. They are divided into EphA and EphB subfamilies and interact with ephrin-A and ephrin-B ligands. Ligand binding induces receptor dimerization and autophosphorylation, triggering downstream signaling cascades that regulate cytoskeletal dynamics, cell shape/movement, proliferation/survival/apoptosis. The Eph/ephrin interaction induces bidirectional signaling.
Tyrosine kinase inhibition (potential)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ephrin Receptor (Eph receptor).